616. Evaluation of In Vitro Susceptibility to Ceftazidime/Avibactam of Clinical Isolates of Carbapenem Nonsusceptible Gram-Negative Bacilli from Colombia

BACKGROUND: Ceftazidime/avibactam (CZA) is a combination of a third-generation cephalosporin and a diazabicyclooctane β-lactamase inhibitor, which is active against a broad range of class A, C and D β-lactamases. In Colombia, high rates of multidrug-resistant Enterobacteriaceae (Ent)and P. aeruginos...

Descripción completa

Detalles Bibliográficos
Autores principales: Appel, Tobias M, Mojica, Maria F, De La Cadena, Elsa, Pallares, Christian, Virginia Villegas, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811018/
http://dx.doi.org/10.1093/ofid/ofz360.684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811018/
http://dx.doi.org/10.1093/ofid/ofz360.684

Ejemplares similares